Delivery of PrEP to Key Populations in Kenya: Applying Coincidence Analysis to Determine Effective Implementation Strategies
向肯尼亚重点人群提供 PrEP:应用巧合分析来确定有效的实施策略
基本信息
- 批准号:10700586
- 负责人:
- 金额:$ 38.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2025-09-14
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAffectAfricaAfrica South of the SaharaClientClinicalConsolidated Framework for Implementation ResearchContinuity of Patient CareCountryCountyDataData AggregationEligibility DeterminationEnsureEpidemicGenderGovernmentHIVHIV SeronegativityIndividualInjecting drug userInjectionsInterviewInvestigationKenyaLeadMeasuresMethodsModelingOutcomeOutcome StudyParticipantPersonsPharmaceutical PreparationsPhasePopulationPopulation GroupPreventionRegimenResearchRiskRoleRunningSiteStructureSurveysSystemTestingUnited StatesVariantWomanYouthcommunity organizationscontextual factorsefficacy trialfemale sex workerimplementation contextimplementation outcomesimplementation scienceimplementation strategyimprovedinnovationinterestmembermen who have sex with mennovelpillpre-exposure prophylaxisprogramsresponseuptake
项目摘要
Project Summary
Since 2012, pre-exposure prophylaxis (PrEP), typically delivered as a daily pill or more recently as a bimonthly
injection, has been available as a method of HIV prevention. Despite PrEP being highly effective at reducing a
person’s risk of acquiring HIV, uptake of the prevention method has been. In this study we will examine
existing programs implementing PrEP and assess which implementation strategies and contextual factors lead
to the best rates of PrEP initiation and persistence; these findings will contribute to improving PrEP delivery
and the ongoing HIV prevention efforts in Kenya. The study has two aims: Aim 1) Identify the implementation
strategies and contextual factors affecting PrEP implementation within clinical and community-based
organizations in Kenya and Aim 2) Determine the combination(s) of implementation strategies and contextual
factors that produce the most effective delivery of PrEP to populations at greatest risk of HIV acquisition. To
achieve Aim 1 we will collect and summarize data through three phases. In Phase 1 we will request aggregate
data from organizations that prescribe PrEP in Kenya to measure the study outcomes (i.e., the proportions of
eligible individuals who start PrEP and who have maintained PrEP use over 3-month and 6-month periods) and
identify preliminary variation in the implementation strategies and site-level contextual factors that may affect
PrEP implementation. In Phase 2 we will conduct quantitative surveys with staff at a subset of sites to assess
the impact of Consolidated Framework for Implementation Research (CFIR) factors and presence or absence
of implementation strategies on PrEP implementation outcomes. In Phase 3 we will complete semi-structured
interviews to gain a more detailed and nuanced understanding of implementation strategies and contextual
factors from Phase 2 responses. To achieve Aim 2 we will conduct Coincidence Analysis (CNA) to determine
the sets of implementation strategies and contextual factors leading to high proportions of eligible individuals
who both start and maintain PrEP (i.e., optimized implementation). CNA is a method of causal inference and
determines the combinations of factors that are minimally necessary or sufficient for an outcome of interest. In
this application we will examine which combinations of contextual factors and implementation strategies result
in optimized PrEP implementation. The models will be run for three outcomes based on the following:
proportion of clients who initiate PrEP; and proportion of clients continuing PrEP use after 3 and 6 months,
each of which will either be dichotomized (high vs. low) or trichotomized (high, medium, low). Additional
factors, representing differences in client populations (e.g., MSM, women, youth) will be included in the
analyses to determine whether unique sets of strategies and factors lead to optimization for different
populations.
项目摘要
自2012年以来,暴露前预防(PrEP),通常作为每日药丸或最近作为双月一次
注射,已被用作预防艾滋病毒的一种方法。尽管PrEP在减少
为了降低一个人感染艾滋病毒的风险,采取了预防方法。在本研究中,我们将研究
实施PrEP的现有计划并评估哪些实施策略和背景因素导致
最佳的PrEP启动率和持续率;这些发现将有助于改善PrEP的提供
以及肯尼亚正在进行的艾滋病预防工作。本研究有两个目标:目标1)确定实施
影响PrEP在临床和社区实施的策略和背景因素
2)确定实施战略和环境战略的组合,
这些因素使PrEP最有效地提供给艾滋病毒感染风险最大的人群。到
为了实现目标1,我们将通过三个阶段收集和总结数据。在第1阶段,我们将请求聚合
来自肯尼亚开PrEP处方的组织的数据,以衡量研究结果(即,的比例
开始PrEP并在3个月和6个月期间维持PrEP使用的合格个人),以及
确定实施战略的初步变化和可能影响的现场层面的背景因素
PrEP实施。在第二阶段,我们将与工作人员在一部分研究中心进行定量调查,
实施研究综合框架因素的影响以及是否存在
关于PrEP实施成果的实施战略。在第三阶段,我们将完成半结构化
访谈,以更详细和细致入微地了解实施战略和背景
第二阶段反应的因素。为了实现目标2,我们将进行重合分析(CNA),以确定
导致符合条件的个人比例高的实施战略和背景因素
开始和维持PrEP的人(即,优化实现)。CNA是一种因果推理方法,
确定对于感兴趣的结果而言最小必要或足够的因素的组合。在
在这个应用程序中,我们将检查哪些上下文因素和实施策略的组合导致
优化PrEP实施。将根据以下三个结果运行模型:
启动PrEP的客户比例;以及在3和6个月后继续使用PrEP的客户比例,
每一个都将被二分(高对低)或二分(高、中、低)。额外
代表客户群体差异的因素(例如,男男性行为者、妇女、青年)将被纳入
分析,以确定是否独特的策略和因素集导致不同的优化
人口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DeAnne Turner其他文献
DeAnne Turner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 38.95万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 38.95万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 38.95万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 38.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists